Variant report

Variant	esv8142
Chromosome Location	chr2:234653225-234664769
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr2:234653876-234654428	HepG2	liver:	n/a	n/a
2	ATF3	chr2:234653988-234654486	A549	lung:	n/a	n/a
3	BCL3	chr2:234653885-234654544	A549	lung:	n/a	n/a
4	BCL3	chr2:234653958-234654499	A549	lung:	n/a	n/a
5	BHLHE40	chr2:234654058-234654451	HepG2	liver:	n/a	n/a
6	CBX3	chr2:234659353-234659614	K562	blood:	n/a	n/a
7	CEBPB	chr2:234653908-234654385	HepG2	liver:	n/a	chr2:234654071-234654082 chr2:234654069-234654086 chr2:234654118-234654130
8	CEBPB	chr2:234657008-234657264	IMR90	lung:	n/a	chr2:234657082-234657093 chr2:234657082-234657093 chr2:234657104-234657115
9	CEBPB	chr2:234653902-234654598	HepG2	liver:	n/a	chr2:234654071-234654082 chr2:234654069-234654086 chr2:234654118-234654130
10	CEBPB	chr2:234656934-234657289	HepG2	liver:	n/a	chr2:234657082-234657093 chr2:234657082-234657093 chr2:234657104-234657115
11	CEBPB	chr2:234653979-234654335	HepG2	liver:	n/a	chr2:234654071-234654082 chr2:234654069-234654086 chr2:234654118-234654130
12	CEBPB	chr2:234654020-234654389	A549	lung:	n/a	chr2:234654071-234654082 chr2:234654069-234654086 chr2:234654118-234654130
13	CEBPB	chr2:234653943-234654318	A549	lung:	n/a	chr2:234654071-234654082 chr2:234654069-234654086 chr2:234654118-234654130
14	CEBPB	chr2:234653892-234654497	A549	lung:	n/a	chr2:234654071-234654082 chr2:234654069-234654086 chr2:234654118-234654130
15	CEBPB	chr2:234653961-234654410	HepG2	liver:	n/a	chr2:234654071-234654082 chr2:234654069-234654086 chr2:234654118-234654130
16	CEBPB	chr2:234656935-234657273	A549	lung:	n/a	chr2:234657082-234657093 chr2:234657082-234657093 chr2:234657104-234657115
17	CEBPD	chr2:234654049-234654478	HepG2	liver:	n/a	n/a
18	CHD2	chr2:234654164-234654273	HepG2	liver:	n/a	n/a
19	CREB1	chr2:234653888-234654608	HepG2	liver:	n/a	n/a
20	CREB1	chr2:234653968-234654547	HepG2	liver:	n/a	n/a
21	CREB1	chr2:234654194-234654509	A549	lung:	n/a	n/a
22	CREB1	chr2:234654062-234654459	A549	lung:	n/a	n/a
23	EP300	chr2:234654030-234654453	HepG2	liver:	n/a	chr2:234654068-234654082
24	EP300	chr2:234653933-234654548	HepG2	liver:	n/a	chr2:234654068-234654082
25	EP300	chr2:234653810-234654542	A549	lung:	n/a	chr2:234654068-234654082 chr2:234653862-234653871
26	EP300	chr2:234653700-234654700	A549	lung:	n/a	chr2:234654068-234654082 chr2:234653862-234653871
27	EP300	chr2:234653868-234654574	HepG2	liver:	n/a	chr2:234654068-234654082
28	FOSL2	chr2:234654000-234654628	HepG2	liver:	n/a	n/a
29	FOSL2	chr2:234653860-234654613	A549	lung:	n/a	n/a
30	FOSL2	chr2:234653946-234654485	HepG2	liver:	n/a	n/a
31	FOSL2	chr2:234654004-234654404	A549	lung:	n/a	n/a
32	FOXA1	chr2:234653871-234654608	HepG2	liver:	n/a	n/a
33	FOXA1	chr2:234653527-234654585	HepG2	liver:	n/a	n/a
34	FOXA1	chr2:234653830-234654570	HepG2	liver:	n/a	n/a
35	FOXA1	chr2:234653906-234654589	HepG2	liver:	n/a	n/a
36	FOXA2	chr2:234653954-234654644	A549	lung:	n/a	n/a
37	FOXA2	chr2:234653884-234654483	HepG2	liver:	n/a	n/a
38	FOXA2	chr2:234653649-234654629	A549	lung:	n/a	n/a
39	FOXA2	chr2:234653696-234654749	HepG2	liver:	n/a	n/a
40	GATA3	chr2:234653893-234654633	A549	lung:	n/a	n/a
41	GATA3	chr2:234653885-234654644	A549	lung:	n/a	n/a
42	HDAC2	chr2:234653853-234654551	HepG2	liver:	n/a	n/a
43	HDAC2	chr2:234653902-234654531	HepG2	liver:	n/a	n/a
44	HNF4A	chr2:234653907-234654493	HepG2	liver:	n/a	chr2:234654285-234654298 chr2:234654285-234654300 chr2:234654281-234654303 chr2:234654233-234654248 chr2:234654285-234654298
45	HNF4A	chr2:234654029-234654486	HepG2	liver:	n/a	chr2:234654285-234654298 chr2:234654285-234654300 chr2:234654281-234654303 chr2:234654233-234654248 chr2:234654285-234654298
46	HNF4A	chr2:234653992-234654483	HepG2	liver:	n/a	chr2:234654285-234654298 chr2:234654285-234654300 chr2:234654281-234654303 chr2:234654233-234654248 chr2:234654285-234654298
47	HNF4G	chr2:234653874-234654479	HepG2	liver:	n/a	chr2:234654285-234654298 chr2:234654285-234654300 chr2:234654281-234654303 chr2:234654285-234654298
48	HNF4G	chr2:234653857-234654583	HepG2	liver:	n/a	chr2:234654285-234654298 chr2:234654285-234654300 chr2:234654281-234654303 chr2:234654285-234654298
49	JUN	chr2:234654021-234654371	HepG2	liver:	n/a	n/a
50	JUN	chr2:234656977-234657137	HepG2	liver:	n/a	chr2:234657101-234657114

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr2:234663937-234663987	GM12892	blood:	n/a
2	chr2:234663937-234663987	GM12892	blood:	n/a
3	chr2:234663729-234663779	LNCaP	prostate:	n/a
4	chr2:234663729-234663779	BE2_C	brain:	n/a
5	chr2:234661536-234661586	PrEC	prostate:	n/a
6	chr2:234661536-234661586	Hepatocyte	liver:	n/a
7	chr2:234663937-234663987	T-47D	breast:	n/a
8	chr2:234664336-234664386	HCPEpiC	choroid plexus:	n/a
9	chr2:234664336-234664386	K562	blood:	n/a
10	chr2:234663900-234663950	HNPCEpiC	eye:	n/a
11	chr2:234653891-234653941	AG09309	skin:	n/a
12	chr2:234663937-234663987	HMEC	breast:	n/a
13	chr2:234655709-234655759	GM06990	blood:	n/a
14	chr2:234663729-234663779	Jurkat	blood:	n/a
15	chr2:234663900-234663950	BE2_C	brain:	n/a
16	chr2:234655709-234655759	GM12892	blood:	n/a
17	chr2:234662401-234662451	HepG2	liver:	n/a
18	chr2:234663937-234663987	NB4	blood:	n/a
19	chr2:234662759-234662809	HEK293	kidney:	embryo
20	chr2:234664336-234664386	ovcar-3	ovarian:	n/a
21	chr2:234653891-234653941	HepG2	liver:	n/a
22	chr2:234661536-234661586	BJ	skin:	n/a
23	chr2:234663937-234663987	ovcar-3	ovarian:	n/a
24	chr2:234663900-234663950	HMEC	breast:	n/a
25	chr2:234663729-234663779	HNPCEpiC	eye:	n/a
26	chr2:234664336-234664386	SKMC	muscle:	n/a
27	chr2:234663900-234663950	Hela-S3	cervix:	n/a
28	chr2:234655709-234655759	AoSMC	blood vessel:	n/a
29	chr2:234662401-234662451	SK-N-MC	brain:	n/a
30	chr2:234663900-234663950	HEK293	kidney:	embryo
31	chr2:234663937-234663987	HRCEpiC	kidney:	n/a
32	chr2:234653891-234653941	NHDF-neo	bronchial:	n/a
33	chr2:234661536-234661586	AG10803	skin:	n/a
34	chr2:234663729-234663779	ECC-1	luminal epithelium:	n/a
35	chr2:234653891-234653941	SAEC	small airway:	n/a
36	chr2:234655709-234655759	HepG2	liver:	n/a
37	chr2:234663729-234663779	MCF10A-Er-Src	breast:	n/a
38	chr2:234663729-234663779	Caco-2	colon:	n/a
39	chr2:234662759-234662809	HCPEpiC	choroid plexus:	n/a
40	chr2:234662759-234662809	HPAEpiC	pulmonary alveolar:	n/a
41	chr2:234655709-234655759	H1-hESC	embryonic stem cell:	embryo
42	chr2:234663729-234663779	HCT-116	colon:	n/a
43	chr2:234655709-234655759	HRPEpiC	eye:	n/a
44	chr2:234662401-234662451	IMR90	lung:	fetal
45	chr2:234662759-234662809	AG04450	lung:	fetal
46	chr2:234661536-234661586	HCPEpiC	choroid plexus:	n/a
47	chr2:234661536-234661586	GM19239	blood:	n/a
48	chr2:234663729-234663779	HEEpiC	esophagus:	n/a
49	chr2:234664336-234664386	HCF	heart:	n/a
50	chr2:234662759-234662809	HepG2	liver:	n/a

No.	Distal block	Cell Line	Cell type
1	chr2:234650134..234652973-chr2:234653062..234655371,2	MCF-7	breast:
2	chr2:234651385..234654197-chr2:234659573..234662296,2	MCF-7	breast:
3	chr17:63274126..63274957-chr2:234657055..234657979,2	MCF-7	breast:
4	chr2:234660399..234662742-chr2:234667989..234670944,2	MCF-7	breast:
5	2:234543708-234558325..2:234649753-234657866	Hela-S3	cervix:

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-HJURP-4	chr2:234663790-234663991	NR_037696
2	lnc-UGT1A1-1	chr2:234661849-234662302	NONHSAT077510
3	lnc-HJURP-4	chr2:234662962-234663437	NR_037696
4	lnc-UGT1A1-1	chr2:234660991-234661189	NONHSAT077510
5	lnc-UGT1A1-1	chr2:234659263-234659366	NONHSAT077510

Variant related genes	Relation type
UGT1A2P	TF binding region
ENSG00000248705	TF binding region
ENSG00000178836	TF binding region
UGT1A1	TF binding region
UGT1A8	TF binding region
DNAJB3	TF binding region
UGT1A2P	CpG island
ENSG00000248705	CpG island
ENSG00000178836	CpG island
UGT1A1	CpG island
UGT1A8	CpG island
DNAJB3	CpG island
ENSG00000242515	chromatin interactions
ENSG00000227802	chromatin interactions
ENSG00000241635	chromatin interactions
ENSG00000234143	chromatin interactions
ENSG00000242366	chromatin interactions

Extended variants
information (count: 528 )
Associated
traits (count: 62 )

Variant overlapped rSNPs/rCNVs (count:528 , 50 per page) page: 1 2 3 4 5 6 7 ... 11

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs560652902	chr2:234653231-234653232	Weak transcription Enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
2	rs574168036	chr2:234653241-234653242	Weak transcription Enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
3	rs28899468	chr2:234653292-234653293	Weak transcription Enhancers	Chromatin interactive region	3 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
4	rs187577100	chr2:234653369-234653370	Weak transcription Enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
5	rs116261344	chr2:234653414-234653415	Weak transcription Enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
6	rs144483920	chr2:234653425-234653426	Weak transcription Enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
7	rs145652010	chr2:234653440-234653441	Weak transcription Enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
8	rs571960868	chr2:234653445-234653446	Weak transcription Enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
9	rs79404275	chr2:234653456-234653457	Weak transcription Enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
10	rs75772634	chr2:234653458-234653459	Weak transcription Enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
11	rs571865422	chr2:234653460-234653461	Weak transcription Enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
12	rs534580707	chr2:234653496-234653497	Weak transcription Enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
13	rs17864703	chr2:234653498-234653499	Weak transcription Enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
14	rs28900378	chr2:234653538-234653539	Weak transcription Enhancers	TF binding region Chromatin interactive region	5 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
15	rs543250877	chr2:234653566-234653567	Weak transcription Enhancers	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
16	rs563141954	chr2:234653592-234653593	Weak transcription Enhancers	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
17	rs528812849	chr2:234653623-234653624	Weak transcription Enhancers	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
18	rs552050904	chr2:234653654-234653655	Weak transcription Enhancers	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
19	rs115414076	chr2:234653707-234653708	Weak transcription Enhancers	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
20	rs542765504	chr2:234653735-234653736	Weak transcription Enhancers	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
21	rs148872010	chr2:234653892-234653893	Weak transcription Enhancers Active TSS	TF binding region CpG island Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
22	rs528500230	chr2:234653915-234653916	Weak transcription Enhancers Active TSS	TF binding region CpG island Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
23	rs13426130	chr2:234653938-234653939	Weak transcription Enhancers Active TSS	TF binding region CpG island Chromatin interactive region	5 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
24	rs191130828	chr2:234653965-234653966	Weak transcription Enhancers Active TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
25	rs565612187	chr2:234653984-234653985	Weak transcription Enhancers Active TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
26	rs531226985	chr2:234654026-234654027	Weak transcription Enhancers Active TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
27	rs190513469	chr2:234654112-234654113	Weak transcription Enhancers Active TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
28	rs376846605	chr2:234654133-234654134	Weak transcription Enhancers Active TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
29	rs567771888	chr2:234654165-234654166	Weak transcription Enhancers Active TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
30	rs530279744	chr2:234654169-234654170	Weak transcription Enhancers Active TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
31	rs548824716	chr2:234654197-234654198	Weak transcription Enhancers Active TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
32	rs565744032	chr2:234654236-234654237	Weak transcription Enhancers	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
33	rs530940349	chr2:234654284-234654285	Weak transcription Enhancers	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
34	rs182919627	chr2:234654285-234654286	Weak transcription Enhancers	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
35	rs28900379	chr2:234654322-234654323	Weak transcription Enhancers	TF binding region Chromatin interactive region	6 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
36	rs571256965	chr2:234654354-234654355	Weak transcription Enhancers	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
37	rs536953064	chr2:234654367-234654368	Weak transcription Enhancers	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
38	rs556800643	chr2:234654382-234654383	Weak transcription Enhancers	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
39	rs11695484	chr2:234654449-234654450	Weak transcription Flanking Active TSS Enhancers	TF binding region Chromatin interactive region	6 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
40	rs148112408	chr2:234654457-234654458	Weak transcription Flanking Active TSS Enhancers	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
41	rs553219755	chr2:234654513-234654514	Weak transcription Flanking Active TSS Enhancers	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
42	rs573273105	chr2:234654538-234654539	Weak transcription Flanking Active TSS Enhancers	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
43	rs377389606	chr2:234654583-234654584	Weak transcription Flanking Active TSS Enhancers	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
44	rs543022659	chr2:234654610-234654611	Weak transcription Flanking Active TSS Enhancers Bivalent Enhancer	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
45	rs188125843	chr2:234654705-234654706	Weak transcription Flanking Active TSS Enhancers Bivalent Enhancer	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
46	rs555344502	chr2:234654730-234654731	Weak transcription Flanking Active TSS Enhancers Bivalent Enhancer	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
47	rs530884234	chr2:234654744-234654745	Weak transcription Flanking Active TSS Enhancers Bivalent Enhancer	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
48	rs544937305	chr2:234654764-234654765	Weak transcription Flanking Active TSS Enhancers Bivalent Enhancer	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
49	rs191765409	chr2:234654775-234654776	Weak transcription Flanking Active TSS Enhancers Bivalent Enhancer	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
50	rs530256545	chr2:234654811-234654812	Weak transcription Flanking Active TSS Enhancers Bivalent Enhancer	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:62)

Disease	PMID	Source
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Medulloblastoma	21979893	CNVD
Ependymoma	16718352	CNVD
Melanoma	18172304	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Acute lymphoblastic leukemia	21980252	CNVD
Breast cancer	17603634	CNVD
Breast cancer	16272173	CNVD
Ewing''s sarcoma	17952124	CNVD
Cancer	21637783	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Liposarcoma	21253554	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Embryonal rhabdomyosarcoma	16790082	CNVD
Autism	16446308	CNVD
Autism	19401682	CNVD
Colorectal cancer	16272173	CNVD
Lung cancer	18438408	CNVD
Acute myeloid leukemia	20729466	CNVD
small cell lung cancer	20016488	CNVD
Biliary cancer	20360734	CNVD
Breast cancer	20360734	CNVD
Coronary artery disease	20360734	CNVD
Crohn''s disease	20360734	CNVD
Hypertension	20360734	CNVD
Rheumatoid arthritis	20360734	CNVD
Type 1 diabetes	20360734	CNVD
Type 2 diabetes	20360734	CNVD
Urothelial carcinoma	21177765	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Cervical cancer	21062161	CNVD
Adenoid cystic carcinoma	18698036	CNVD
Myofibroblastic sarcoma	19369631	CNVD
Chordoma	18071362	CNVD
Developmental delay	21147756	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Cancer	22429812	CNVD
Bladder cancer	21909424	CNVD
Renal cell carcinoma	21668985	CNVD
Breast cancer	21785460	CNVD
Prostate cancer	18632612	CNVD
Malignant fibrous histiocytomas	21085701	CNVD
Wilms tumour	21544195	CNVD
Esophageal adenocarcinoma	18519675	CNVD
prenatal diagnosis	22389664	CNVD
Myelofibrosis	22110671	CNVD
Invasive pancreatic ductal carcinoma	16982739	CNVD
Mental retardation	20152051	CNVD
Cancer	21183584	CNVD
Albright''s disease	22277900	CNVD
Brachydactyly-Mental Retardation Syndrome	22470819	CNVD
T-cell acute lymphoblastic leukemia	18185524	CNVD
Colorectal cancer	19359472	CNVD
Autism	18414403	CNVD
Chronic myeloid leukemia	21384125	CNVD
Pancreatic cancer	17952125	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD
Non-syndromic sensorineural hearing loss	21293372	CNVD

Chromatin state (count:64 , 50 per page) page: 1 2

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr2:234620400-234659200	Weak transcription	Colonic Mucosa	Colon
2	chr2:234626600-234668400	Weak transcription	NHEK	skin
3	chr2:234646400-234666600	Weak transcription	Stomach Mucosa	stomach
4	chr2:234647800-234655000	Weak transcription	Gastric	stomach
5	chr2:234649800-234658800	Weak transcription	Rectal Mucosa Donor 29	rectum
6	chr2:234652600-234654400	Enhancers	Liver	Liver
7	chr2:234652600-234654600	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
8	chr2:234652800-234658200	Weak transcription	Foreskin Keratinocyte Primary Cells skin03	Skin
9	chr2:234652800-234659200	Weak transcription	Foreskin Keratinocyte Primary Cells skin02	Skin
10	chr2:234653200-234654400	Enhancers	HepG2	liver
11	chr2:234653200-234655600	Enhancers	Fetal Intestine Small	intestine
12	chr2:234653400-234653800	Enhancers	A549	lung
13	chr2:234653800-234654200	Active TSS	A549	lung
14	chr2:234654200-234654800	Enhancers	Small Intestine	intestine
15	chr2:234654200-234655000	Enhancers	A549	lung
16	chr2:234654200-234655400	Enhancers	Duodenum Mucosa	Duodenum
17	chr2:234654200-234655400	Enhancers	Fetal Intestine Large	intestine
18	chr2:234654400-234654600	Flanking Active TSS	HepG2	liver
19	chr2:234654400-234656000	Flanking Active TSS	Liver	Liver
20	chr2:234654600-234655800	Bivalent Enhancer	HepG2	liver
21	chr2:234655000-234655200	Flanking Active TSS	A549	lung
22	chr2:234655000-234655600	Enhancers	Gastric	stomach
23	chr2:234655200-234655400	Enhancers	A549	lung
24	chr2:234655400-234655600	Flanking Active TSS	A549	lung
25	chr2:234655400-234656200	Enhancers	Pancreas	Pancrea
26	chr2:234655600-234656200	Enhancers	A549	lung
27	chr2:234656000-234656600	Enhancers	Liver	Liver
28	chr2:234656200-234659000	Weak transcription	A549	lung
29	chr2:234656600-234657000	Flanking Active TSS	Liver	Liver
30	chr2:234657000-234657200	Enhancers	Liver	Liver
31	chr2:234657200-234657600	Flanking Active TSS	Liver	Liver
32	chr2:234657600-234658000	Active TSS	Liver	Liver
33	chr2:234658000-234658200	Flanking Active TSS	Liver	Liver
34	chr2:234658200-234660600	Enhancers	Liver	Liver
35	chr2:234658200-234664000	Strong transcription	Foreskin Keratinocyte Primary Cells skin03	Skin
36	chr2:234659200-234659800	ZNF genes & repeats	Foreskin Keratinocyte Primary Cells skin02	Skin
37	chr2:234659600-234660200	ZNF genes & repeats	Colonic Mucosa	Colon
38	chr2:234659600-234660800	ZNF genes & repeats	Fetal Intestine Small	intestine
39	chr2:234659800-234661800	Weak transcription	Foreskin Keratinocyte Primary Cells skin02	Skin
40	chr2:234660000-234666200	Weak transcription	Rectal Mucosa Donor 29	rectum
41	chr2:234660200-234666400	Weak transcription	Colonic Mucosa	Colon
42	chr2:234660600-234663800	Weak transcription	Liver	Liver
43	chr2:234661400-234662000	Enhancers	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
44	chr2:234661400-234662200	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
45	chr2:234661800-234662200	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
46	chr2:234661800-234664200	Strong transcription	Foreskin Keratinocyte Primary Cells skin02	Skin
47	chr2:234663600-234664000	ZNF genes & repeats	A549	lung
48	chr2:234663800-234664000	Active TSS	H1 Derived Mesenchymal Stem Cells	ES cell derived
49	chr2:234663800-234664000	ZNF genes & repeats	iPS DF 19.11 Cell Line	embryonic stem cell
50	chr2:234663800-234664000	Bivalent Enhancer	Foreskin Melanocyte Primary Cells skin01	Skin

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links